1. Home
  2. UPLD vs ALLR Comparison

UPLD vs ALLR Comparison

Compare UPLD & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$0.70

Market Cap

17.3M

Sector

Technology

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.73

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
ALLR
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
19.3M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
UPLD
ALLR
Price
$0.70
$1.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.75
$9.75
AVG Volume (30 Days)
351.0K
212.0K
Earning Date
05-01-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
$320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.77
52 Week High
$3.90
$2.35

Technical Indicators

Market Signals
Indicator
UPLD
ALLR
Relative Strength Index (RSI) 47.41 67.92
Support Level $0.68 $0.92
Resistance Level $0.74 $1.79
Average True Range (ATR) 0.11 0.17
MACD -0.01 0.01
Stochastic Oscillator 7.99 93.98

Price Performance

Historical Comparison
UPLD
ALLR

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: